創世紀(300083.SZ):勁輝國際所持1100萬股將被司法拍賣
格隆匯1月24日丨創世紀(300083.SZ)公佈,公司於2022年1月24日查詢京東司法拍賣網獲悉:公司持股5%以上股東勁輝國際企業有限公司(“勁輝國際”)持有的創世紀部分股份將被司法拍賣。
廣東省東莞市中級人民法院擬在京東拍賣網絡平台於2022年2月23日依法拍賣被執行人勁輝國際持有的證券簡稱“創世紀”(證券代碼:300083,股份性質:無限售流通股)股票共1100萬股。具體時間為:2022年2月23日14時至2022年2月24日14時止(延時除外)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.